Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta Blockers in Pulmonary Arterial Hypertension (PAH) A Pilot Study of Efficacy and Safety

NCT02120339 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02120339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02120339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta Blockers in Pulmonary Arterial Hypertension (PAH) A Pilot Study of Efficacy and Safety
Lead sponsor
University of Minnesota
Phase
Phase 1
Overall status
Terminated
Start date
May 31, 2014
Completion date
June 30, 2016
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac mri <40, pulmonary hypertension